Renaissance Technologies - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 2 filers reported holding ROYALTY PHARMA PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$13,114
-44.6%
483,200
-37.3%
0.02%
-35.3%
Q2 2023$23,691
-49.5%
770,700
-40.8%
0.03%
-45.2%
Q1 2023$46,871
+36.5%
1,300,900
+49.7%
0.06%
+31.9%
Q4 2022$34,343
-99.5%
869,000
+372.5%
0.05%
+487.5%
Q1 2022$7,165,000
-77.5%
183,900
-77.0%
0.01%
-80.0%
Q4 2021$31,844,000
+12.4%
799,100
+2.0%
0.04%
+8.1%
Q3 2021$28,319,000
-16.6%
783,600
-5.4%
0.04%
-11.9%
Q2 2021$33,964,000828,6000.04%
Other shareholders
ROYALTY PHARMA PLC shareholders Q4 2023
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders